Leukemia Posts on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Is stopping nilotinib treatment safe in patients with chronic myelogenous leukemia that have achieved a stable response?

Posted by on Oct 12, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of stopping nilotinib treatment in patients with chronic-phase chronic myelogenous leukemia.  This study concluded that stopping nilotinib after two years of consolidation treatment was safe and effective.  Some background...

Read More

Stem cell transplant in patients in second complete remission with core binding factor acute myeloid leukemia.

Posted by on Sep 30, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of allogeneic transplantation in patients with core-binding factor acute myeloid leukemia in second complete remission.   This study concluded that transplant was effective in a large proportion of these patients.   Some background Core binding factor acute myeloid...

Read More

Searching for patients with different types of leukemia to test modified stem cell transplants donated by relatives

Posted by on Sep 20, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of modified stem cell transplants (SCT) donated by patient relatives, which have certain immune cells removed to prevent transplant rejection in patients with leukemia and lymphoma. The main outcome will be the maximum dose of SCT that can be given safely and is effective. This study is recruiting...

Read More

Decitabine, cytarabine and umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia

Posted by on Sep 17, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the combination of low-dose decitabine, medium-dose cytarabine and umbilical cord blood infusion as a consolidation therapy for elderly patients with acute myeloid leukemia.   This study concluded that this treatment combination was effective in these patients.   Some...

Read More

Surviving cancer – is there a greater risk of cardiovascular disease long-term?

Posted by on Sep 16, 2019 in Leukemia | 0 comments

In a nutshell This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors.  They found that cancer survivors have a higher risk of CVD. Some background Improved cancer detection and treatment has increased the rates of survival. The number of cancer survivors living for more than 10 years is growing. Some...

Read More

Evaluating the TLI-ATG conditioning regimen before allogeneic stem cell transplantation in patients with lymphoma or leukemia

Posted by on Sep 13, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of total lymphoid irradiation and anti-thymocyte globulin (TLI-ATG) conditioning before stem cell transplantation (SCT) in patients with lymphoma or leukemia. This study concluded that this regimen was well-tolerated and effective, especially for patients who had multiple lines of prior...

Read More

Stem cell transplant after blinatumomab in patients with relapsed or unresponsive acute lymphoblastic leukemia

Posted by on Sep 13, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes for patients who underwent allogeneic hematopoietic stem cell transplant after treatment with blinatumomab.  This study concluded that survival was driven by the response to study treatment and by salvage status regardless of transplant status.   Some...

Read More